TY - JOUR
T1 - IkB kinase phosphorylation of SNAP-23 controls platelet secretion
AU - Karim, Zubair A.
AU - Zhang, Jinchao
AU - Banerjee, Meenakshi
AU - Chicka, Michael C.
AU - Al Hawas, Rania
AU - Hamilton, Tara R.
AU - Roche, Paul A.
AU - Whiteheart, Sidney W.
N1 - Publisher Copyright:
© 2013 by The American Society of Hematology.
PY - 2013/5/30
Y1 - 2013/5/30
N2 - Platelet secretion plays a key role in thrombosis, thus the platelet secretory machinery offers a unique target to modulate hemostasis. We report the regulation of platelet secretion via phosphorylation of SNAP-23 at Ser95. Phosphorylation of this t-soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) occurs upon activation of known elements of the platelet signaling cascades (ie, phospholipase C, [Ca2+]i, protein kinase C) and requires IκB kinase (IKK)-β. Other elements of the nuclear factor kB/IkB cascade (ie, IKK-α,-β,-γ/NEMO and CARMA/MALT1/Bcl10 complex) are present in anucleate platelets and IkB is phosphorylated upon activation, suggesting that this pathway is active in platelets and implying a nongenomic role for IKK. Inhibition of IKK-β, either pharmacologically (with BMS-345541, BAY11-7082, or TPCA-1) or by genetic manipulation (platelet factor 4 Cre:IKK-βflox/flox), blocked SNAP-23 phosphorylation, platelet secretion, and SNARE complex formation; but, had no effect on platelet morphology or other metrics of platelet activation. Consistently, SNAP-23 phosphorylation enhanced membrane fusion of SNARE-containing proteoliposomes. In vivo studies with IKK inhibitors or platelet-specific IKK-β knockout mice showed that blocking IKK-β activity significantly prolonged tail bleeding times, suggesting that currently available IKK inhibitors may affect hemostasis.
AB - Platelet secretion plays a key role in thrombosis, thus the platelet secretory machinery offers a unique target to modulate hemostasis. We report the regulation of platelet secretion via phosphorylation of SNAP-23 at Ser95. Phosphorylation of this t-soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) occurs upon activation of known elements of the platelet signaling cascades (ie, phospholipase C, [Ca2+]i, protein kinase C) and requires IκB kinase (IKK)-β. Other elements of the nuclear factor kB/IkB cascade (ie, IKK-α,-β,-γ/NEMO and CARMA/MALT1/Bcl10 complex) are present in anucleate platelets and IkB is phosphorylated upon activation, suggesting that this pathway is active in platelets and implying a nongenomic role for IKK. Inhibition of IKK-β, either pharmacologically (with BMS-345541, BAY11-7082, or TPCA-1) or by genetic manipulation (platelet factor 4 Cre:IKK-βflox/flox), blocked SNAP-23 phosphorylation, platelet secretion, and SNARE complex formation; but, had no effect on platelet morphology or other metrics of platelet activation. Consistently, SNAP-23 phosphorylation enhanced membrane fusion of SNARE-containing proteoliposomes. In vivo studies with IKK inhibitors or platelet-specific IKK-β knockout mice showed that blocking IKK-β activity significantly prolonged tail bleeding times, suggesting that currently available IKK inhibitors may affect hemostasis.
UR - http://www.scopus.com/inward/record.url?scp=84880801800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880801800&partnerID=8YFLogxK
U2 - 10.1182/blood-2012-11-470468
DO - 10.1182/blood-2012-11-470468
M3 - Article
C2 - 23613522
AN - SCOPUS:84880801800
SN - 0006-4971
VL - 121
SP - 4567
EP - 4574
JO - Blood
JF - Blood
IS - 22
ER -